Some may look at the volatility and uncertainly of the Alternative Health Fund as uneasy and others may see it as an incredible opportunity to be at the forefront of this exciting industry that has opened up in Canada. If you are the latter, we invite you to watch the replay of the live-stream event from Wednesday, Nov. 21 2018, hosted by Charles Taerk, Sub-Advisor to Ninepoint Alternative Health Fund (CEO, Faircourt Asset Management) where Charles delves into some important questions with Peter Aceto, CEO of CannTrust Holdings Inc., and Greg Engel, CEO of Organigram Holdings.
A few key updates about the Ninepoint Alternative Health Fund and the cannabis sector:
Year to date (as of 2/28/19) 33.95% rate of return 1 year ROR (as of 2/28/19) 49.26%
Over the last 24 months, the world has gone from 10 countries to 40 countries, representing an addressable market of over 1.2 billion people, that now have some form of cannabis medical legalization.
There are now 32 states that are legal for medical and 10 States plus Washington DC that are legal for recreational use. All together that represents approximately 70% of the US population. Despite limitations at the federal level, these markets are operating effectively with leading operators generating significant revenues and growing cash flows.
Contact us to see if the Ninepoint Alternative Health Fund is the right addition to your portfolio.
(Source:https://www.ninepoint.com/funds/ninepoint-alternative-health-fund/#fund-story) Contact us to see if the Ninepoint Alternative Health fund is the right addition to your portfolio.